Clinical Trial Update: The Effect of Erigeron Injection on Acute Cerebral Infarction Serum VEGF, MMP-9 and EPC Levels [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Erigeron injection in acute cerebral infarction, with biomarker endpoints including VEGF, MMP-9, and endothelial progenitor ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Infarction
• Stroke

Drugs mentioned

• Erigeron injection

Snippet

Sponsor: Guangzhou University of Traditional Chinese Medicine | Conditions: Cerebral Infarction | Phase 4 | Status: UNKNOWN